The antiperoxidative activity of Liv.52 prevents the loss of functional integrity of the cell membrane, maintains cytochrome P-450 (a large and diverse group of enzymes, which catalyze the oxidation of organic substances), hastens the recovery period and ensures early restoration of hepatic functions in infective .

The drug is an inhibitor of the enzyme peptidyl. It inhibits the angiotensin-converting enzyme, which catalyzes the conversion of angiotensin I to vasoconstrictor peptide angiotensin II. Angiotensin II also stimulates the secretion of aldosterone by the adrenal cortex. Inhibition of ACE leads to reduced concentrations of angiotensin II, resulting in low aldosterone secretion. The decrease in the latter leads to an increase in the content of potassium in the blood serum. Since the mechanism is believed to be based on the inhibition of the renin-angiotensin-aldosterone system, it reduces blood pressure even in patients with hypertension with low renin levels.

Cardioselective beta-1 blocker. Does not have a membrane-stabilizing action and does not have an internal AGR. Has antihypertensive, anti-angiogenic and antiarrhythmic action. It is used for IHD, angina pectoris, unstable angina, myocardial infarction, arterial hypertension, hypertensive crisis, tachycardia, thyrotoxicosis.

ACE inhibitor. After hydrolysis, Benazepril is converted to an active metabolite, benazeprilate, which inhibits ACE and thereby blocks the conversion of angiotensin I to angiotensin II and reduces the vasoconstrictive effect of angiotensin II and its stimulating effect on aldosterone production. Due to the venodilating effect, it also reduces the preload on the heart. Effective for arterial hypertension, CHF (as part of combination therapy)

An antifungal agent from the group of imidazole derivatives for external and local applications reduces the synthesis of ergosterol, which is a part of the cell membrane of the microbial wall and leads to a change in its structure and properties. In fungicidal concentrations, it interacts with mitochondrial and peroxidase enzymes, leading to an increase in the concentration of hydrogen peroxide to toxic levels, which also contributes to the destruction of fungal cells. The pills are active against pathogenic dermatophytes, pathogens of multi-colored lichen, erythrasma, gram-positive and gram-negative bacteria.

Lovegra is Sildenafil and given to women to increase genital blood flow in order to obtain vaginal compliance and boost libido in women.

It is a sulfonamide diuretic that is pharmacologically related to thiazide diuretics. The medicine inhibits sodium reabsorption in the cortical segment of the kidneys. It increases the excretion of sodium and chlorides in the urine and the excretion of potassium and magnesium, thus increasing diuresis. The antihypertensive effect of the active components appears at doses at which the diuretic effect is insignificant. Moreover, its antihypertensive effect persists even in patients with hypertension.

Lquin Tablet is an antibiotic medicine. It is used for the treatment of bacterial infection of the lungs, throat, airways, nose, ears, urinary tract, skin and soft tissues. It contains levofloxacin.

The medicine is a potent agent that reduces intraocular pressure, belongs to the group of synthetic prostanoid. The mechanism of action, through which Lumigan reduces intraocular pressure in humans results in increasing of the outflow of intraocular fluid through the trabecular mesh and in increasing of the outflow from the uveoscleral eye. The decrease in intraocular pressure begins around 4 hours after the first application. The maximum effect is achieved within approximately 8-12 hours. The effect lasts at least 24 hours.

Antidepressant; a specific inhibitor of serotonin reuptake by neurons of the brain. Has no stimulating or sedative effect, does not affect choline, muscarin-, histamine- and adrenergic processes. The therapeutic effect develops 1-4 weeks after the initiation of therapy.

Antiepileptic agent; binds to the additional subunit (a2-delta protein) of the potential-dependent Ca2 + -channels in the CNS, which promotes the manifestation of analgesic and anticonvulsant action. Reduction in the frequency of seizures begins within the first week.